Release Date: 2024-06-10

Imaging in Prostate Cancer

Ilyas Dundar (Author)

Release Date: 2024-06-10

Prostate cancer (PCa) remains a significant health concern impacting millions of men around the globe. Screening, diagnosis, and treatment of PCa have improved significantly over the past few years. In recent years, advancements in modern imaging technology have enhanced early and initial diagnosis, as well as the detection of distant metastases and recurrences.In recent years, [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inThe Radiology of Cancer
    First Page203
    Last Page215
    DOIhttps://doi.org/10.69860/nobel.9786053359364.17
    Page Count13
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

    Prostate cancer (PCa) remains a significant health concern impacting millions of men around the globe. Screening, diagnosis, and treatment of PCa have improved significantly over the past few years. In recent years, advancements in modern imaging technology have enhanced early and initial diagnosis, as well as the detection of distant metastases and recurrences.In recent years, there have been notable advancements in contemporary imaging methodologies, leading to substantial improvements in the detection and diagnostic assessment of PCa, thus advancing patient care. Multiparametric MRI and MR/TRUS fusion biopsy have enhanced initial detection and prognosis stratification, while prostate-specific membrane antigen hybrid imaging has enhanced staging and the identification of cancer recurrence, especially in high- risk individuals. The utilization of mpMRI is becoming increasingly widespread and rapidly integrated into routine clinical practice for risk stratification of lesions suspected of clinically significant PCa, assessment of the local-regional extent and staging of identified lesions, treatment planning, and patient management. In this section, an overview of imaging methods for PCa treatment will be presented based on the literature.

    Ilyas Dundar (Author)
    Associate Professor, Van Yuzuncu Yil University
    https://orcid.org/0000-0002-1429-077X
    3Associate Professor İlyas Dündar completed his primary education at Van İnönü Primary School (1996), his secondary education at Van İkinisan Secondary School (1997-2000), and his high school education at Van Milli Piyango Anatolian High School (2000-2004). In 2005, he was admitted to Istanbul University Istanbul Faculty of Medicine and received his medical degree in 2011. Between 2011 and 2013, he worked as a general practitioner in Ağrı-Patnos and Van. In 2013, he began his radiology residency at the Department of Radiology, Van Yüzüncü Yıl University Faculty of Medicine, working as a research assistant. In 2018, he became a specialist physician and started working at Bingöl State Hospital. In 2020, he transferred from Bingöl State Hospital to the Department of Radiology, Van Yüzüncü Yıl University Faculty of Medicine, as an Assistant Professor. Dr. Dündar received the title of Associate Professor in 2022 and was appointed to the Associate Professor position at Van Yüzüncü Yıl University Faculty of Medicine in 2023. He has authored many research articles, oral presentations and poster presentations throughout his research life. Dr. Dündar is a member of many professional organizations including Turkish Society of Radiology, European Society of Radiology, Turkish Magnetic Resonance Society and is currently working in the fields of Urogenital and Abdominal Radiology at Van Yüzüncü Yıl University Faculty of Medicine.

    • Halk Sağlığı Genel Müdürlüğü. Türkiye Kanser İstatistikleri 2018. Ankara; 2022.

    • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019 Jan 1;69(1):7–34.

    • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov 1;68(6):394–424.

    • MB A, SB E, editors. American Joint Committee on Cancer Cancer Staging Manual. 8th ed. Switzerland: Springer; 2017.

    • Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int. 2003 Jun;91(9):789–94.

    • Lee CH, Akin-Olugbade O, Kirschenbaum A. Overview of Prostate Anatomy, Histology, and Pathology. Endocrinol Metab Clin North Am. 2011 Sep 1;40(3):565–75.

    • Villeirs GM, Verstraete KL, De Neve WJ, De Meerleer GO. Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists. Radiother Oncol. 2005 Jul 1;76(1):99–106.

    • Dunn MW. Prostate Cancer Screening. Semin Oncol Nurs. 2017 May 1;33(2):156–64.

    • Attard G, Parker C, Eeles RA, Schröder F, Tomlins SA, Tannock I, et al. Prostate cancer. Lancet (London, England). 2016 Jan 2;387(10013):70–82.

    • Mazaheri Y, Shukla-Dave A, Muellner A, Hricak H. MR imaging of the prostate in clinical practice. MAGMA. 2008 Nov;21(6):379–92.

    • Xiang J, Yan H, Li J, Wang X, Chen H, Zheng X. Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis. World J Surg Oncol. 2019 Feb 13;17(1).

    • McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12(12):897–906.

    • Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast TH, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol. 1993;24(8):819–32.

    • Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, et al. The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40(2):244–52.

    • Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. Eur Urol. 2018 Apr 1;73(4):560–9.

    • Turkbey B, Choyke PL. Prostate cancer imaging: A special focus issue from Future Oncology. Futur Oncol. 2016 Nov 1;12(21):2389–91.

    • Padhani AR, Lecouvet FE, Tunariu N, Koh DM, De Keyzer F, Collins DJ, et al. Rationale for Modernising Imaging in Advanced Prostate Cancer. Eur Urol Focus. 2017 Apr 1;3(2–3):22339.

    • Donohoe KJ, Cohen EJ, Giammarile F, Grady E, Greenspan BS, Henkin RE, et al. Appropriate use criteria for bone scintigraphy in prostate and breast cancer: summary and excerpts. Soc Nuclear Med; 2017.

    • Bostwick DG, Pacelli A, Blute M, Roche P, Murphy GP. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer Interdiscip Int J Am Cancer Soc. 1998;82(11):2256–61.

    • Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, et al. 18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer. J Nucl Med. 2015 Jul 1;56(7):1003–10.

    • Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, et al. Diagnostic accuracy of 68Ga-PSMA-11 PET/MRI compared with multiparametric MRI in the detection of prostate cancer. Radiology. 2018 Dec 1;289(3):730–7.

    • Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019 Sep 1;76(3):340–51.

    • Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage t1 c) prostate cancer. Jama. 1994;271(5):368–74.

    • Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018 May 10;378(19):1767–77.

    • Radtke JP, Schwab C, Wolf MB, Freitag MT, Alt CD, Kesch C, et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. 2016;70(5):846–53.

    • Surasi DSS, Chapin B, Tang C, Ravizzini G, Bathala TK. Imaging and Management of Prostate Cancer. Semin Ultrasound CT MR. 2020 Apr 1;41(2):207–21.

    • Ayala AG, Ro JY, Babaian R, Troncoso P, Grignon DJ. The Prostatic Capsule: Does It Exist?: Its Importance in the Staging and Treatment of Prostatic Carcinoma. Am J Surg Pathol. 1989;13(1).

    onix_3.0::thothThoth ONIX 3.0
    onix_3.0::project_museProject MUSE ONIX 3.0
    onix_3.0::oapenOAPEN ONIX 3.0
    onix_3.0::jstorJSTOR ONIX 3.0
    onix_3.0::google_booksGoogle Books ONIX 3.0
    onix_3.0::overdriveOverDrive ONIX 3.0
    onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
    csv::thothThoth CSV
    json::thothThoth JSON
    kbart::oclcOCLC KBART
    bibtex::thothThoth BibTeX
    doideposit::crossrefCrossRef DOI deposit
    onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
    marc21record::thothThoth MARC 21 Record
    marc21markup::thothThoth MARC 21 Markup
    marc21xml::thothThoth MARC 21 XML

    Share This Chapter!